Barostim Neo System
by Cvrx, Inc. United States PMA
PMA P180050 Product code DSR
Overview
The Barostim Neo System is a Stimulator, Carotid Sinus Nerve (per OpenFDA nomenclature), designed to modulate baroreflex activity via electrical stimulation of the carotid sinus nerve. It is classified as a Class III device under FDA regulations (870.3850) and is intended for patients with symptomatic heart failure who remain unstable despite guideline-directed medical therapy.
This system is implanted surgically and is intended for long-term use. It is supplied sterile and requires surgical implantation by a qualified healthcare provider, with no indication of single-use or reusable status. The device is not MRI-safe, and its use is authorized under FDA_PMA (PMA Number: P180050) for the specified patient population. Storage and handling follow standard sterile surgical implant protocols as defined by regulatory guidelines.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP180050 | Date16 Aug 2019 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA PMA Active
Specification
- Generic Name
- Stimulator, carotid sinus nerve
- PMA Number
- FDA Product Code
- DSR
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3850
- Advisory Committee
- Cardiovascular
- FDA Decision
- APPR Approved
Other devices from Cvrx, Inc.
Properties & raw data
Show properties, registry sources and raw records
Sources (1)
- FDA PMA P180050